172 related articles for article (PubMed ID: 34696935)
21. Recombinant urease and urease DNA of Coccidioides immitis elicit an immunoprotective response against coccidioidomycosis in mice.
Li K; Yu JJ; Hung CY; Lehmann PF; Cole GT
Infect Immun; 2001 May; 69(5):2878-87. PubMed ID: 11292702
[TBL] [Abstract][Full Text] [Related]
22. The Rise of
Van Dyke MCC; Thompson GR; Galgiani JN; Barker BM
Front Immunol; 2019; 10():2188. PubMed ID: 31572393
[TBL] [Abstract][Full Text] [Related]
23. Immune response of vaccinated and non-vaccinated mice to Coccidioides posadasii infection.
Xue J; Hung CY; Yu JJ; Cole GT
Vaccine; 2005 May; 23(27):3535-44. PubMed ID: 15855012
[TBL] [Abstract][Full Text] [Related]
24. A recombinant beta-1,3-glucanosyltransferase homolog of Coccidioides posadasii protects mice against coccidioidomycosis.
Delgado N; Xue J; Yu JJ; Hung CY; Cole GT
Infect Immun; 2003 Jun; 71(6):3010-9. PubMed ID: 12761077
[TBL] [Abstract][Full Text] [Related]
25. [A case of coccidioidomycosis in Turkey imported from the United States of America].
Başaran S; Karabıçak N; Şimşek Yavuz S; Wiederhold NP; Şafak S; Sarıbuğa A; Sutton DA; Bingöl Z; Çağatay A; Özsüt H; Kılıçaslan Z; Eraksoy H
Mikrobiyol Bul; 2017 Apr; 51(2):183-190. PubMed ID: 28566083
[TBL] [Abstract][Full Text] [Related]
26. Resistance to Coccidioides immitis in mice after immunization with recombinant protein or a DNA vaccine of a proline-rich antigen.
Abuodeh RO; Shubitz LF; Siegel E; Snyder S; Peng T; Orsborn KI; Brummer E; Stevens DA; Galgiani JN
Infect Immun; 1999 Jun; 67(6):2935-40. PubMed ID: 10338502
[TBL] [Abstract][Full Text] [Related]
27. Genetic vaccination against Coccidioides immitis: comparison of vaccine efficacy of recombinant antigen 2 and antigen 2 cDNA.
Jiang C; Magee DM; Quitugua TN; Cox RA
Infect Immun; 1999 Feb; 67(2):630-5. PubMed ID: 9916069
[TBL] [Abstract][Full Text] [Related]
28. Role of signal sequence in vaccine-induced protection against experimental coccidioidomycosis.
Jiang C; Magee DM; Ivey FD; Cox RA
Infect Immun; 2002 Jul; 70(7):3539-45. PubMed ID: 12065493
[TBL] [Abstract][Full Text] [Related]
29. Protein expression profiling of Coccidioides posadasii by two-dimensional differential in-gel electrophoresis and evaluation of a newly recognized peroxisomal matrix protein as a recombinant vaccine candidate.
Orsborn KI; Shubitz LF; Peng T; Kellner EM; Orbach MJ; Haynes PA; Galgiani JN
Infect Immun; 2006 Mar; 74(3):1865-72. PubMed ID: 16495561
[TBL] [Abstract][Full Text] [Related]
30. Safety, antigenicity, and efficacy of a recombinant coccidioidomycosis vaccine in cynomolgus macaques (Macaca fascicularis).
Johnson SM; Lerche NW; Pappagianis D; Yee JL; Galgiani JN; Hector RF
Ann N Y Acad Sci; 2007 Sep; 1111():290-300. PubMed ID: 17347333
[TBL] [Abstract][Full Text] [Related]
31. Safety, tolerability, and immunogenicity of a recombinant, genetically engineered, live-attenuated vaccine against canine blastomycosis.
Wüthrich M; Krajaejun T; Shearn-Bochsler V; Bass C; Filutowicz HI; Legendre AM; Klein BS
Clin Vaccine Immunol; 2011 May; 18(5):783-9. PubMed ID: 21367980
[TBL] [Abstract][Full Text] [Related]
32. Some evidence for the development of a phagocytic response by polymorphonuclear leukocytes recovered from the venous blood of dogs inoculated with Coccidioides immitis or vaccinated with an irradiated spherule vaccine.
Wegner TN; Reed RE; Trautman RJ; Beavers CD
Am Rev Respir Dis; 1972 May; 105(5):845-9. PubMed ID: 5020634
[No Abstract] [Full Text] [Related]
33. Multivalent recombinant protein vaccine against coccidioidomycosis.
Tarcha EJ; Basrur V; Hung CY; Gardner MJ; Cole GT
Infect Immun; 2006 Oct; 74(10):5802-13. PubMed ID: 16988258
[TBL] [Abstract][Full Text] [Related]
34. Retrospective analysis of cutaneous lesions in 23 canine and 17 feline cases of coccidioidomycosis seen in Arizona, USA (2009-2015).
Simões DM; Dial SM; Coyner KS; Schick AE; Lewis TP
Vet Dermatol; 2016 Oct; 27(5):346-e87. PubMed ID: 27397725
[TBL] [Abstract][Full Text] [Related]
35. Antibiotic control of tissue reactions in dogs vaccinated with viable cells of Coccidioides immitis.
Castleberry MW; Converse JL; Soto PJ
J Bacteriol; 1964 May; 87(5):1216-20. PubMed ID: 5874542
[TBL] [Abstract][Full Text] [Related]
36. The Quest for a Vaccine Against Coccidioidomycosis: A Neglected Disease of the Americas.
Kirkland TN
J Fungi (Basel); 2016 Dec; 2(4):. PubMed ID: 29376949
[TBL] [Abstract][Full Text] [Related]
37. Risk Factors and Spatial Distribution of Canine Coccidioidomycosis in California, 2005-2013.
Grayzel SE; Martínez-López B; Sykes JE
Transbound Emerg Dis; 2017 Aug; 64(4):1110-1119. PubMed ID: 26801836
[TBL] [Abstract][Full Text] [Related]
38. Development of vaccines for coccidioidomycosis.
Levine HB; Pappagianis D; Cobb JM
Mycopathol Mycol Appl; 1970; 41(1):177-85. PubMed ID: 4999877
[No Abstract] [Full Text] [Related]
39. Immunization of mice against coccidioidomycosis.
CONVERSE JL; CASTLEBERRY MW; BESEMER AR; SNYDER EM
J Bacteriol; 1962 Jul; 84(1):46-52. PubMed ID: 13881007
[TBL] [Abstract][Full Text] [Related]
40. Novel strategies to enhance vaccine immunity against coccidioidomycosis.
Cole GT; Hung CY; Sanderson SD; Hurtgen BJ; Wüthrich M; Klein BS; Deepe GS; Ostroff GR; Levitz SM
PLoS Pathog; 2013; 9(12):e1003768. PubMed ID: 24367252
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
